PUBLIC CONTRACT · 2024
Vários medicamentos
- Contract value
- €37,947.76
- Signed on
- 18 April 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10705346PUBLISHED DESCRIPTION
61010024 - AQ URGENTE MEDICAMENTOS
Parties involved
- Awardee
- NeuraxPharm; OCTAPHARMA, PRODUTOS FARMACÊUTICOS, LDA.; MOONSURGE-MATERIAL MEDICO,LDA.; Sanofi - Produtos Farmacêuticos, Lda; SANDOZ FARMACÊUTICA, LDA.; FRESENIUS KABI PHARMA PORTUGAL, LDA.; JANSSEN CILAG FARMACEUTICA, LDA.; BAXTER MEDICO – FARMACEUTICA; MYLAN, LDA; LABORATÓRIO MEDINFAR - PRODUTOS FARMACÊUTICOS, SA; ROCHE FARMACEUTICA QUIMICA, LDA; LABESFAL, Laboratório Almiro S.A.; Vifor Pharma Portugal, S.A.; ITF Medivida, Produtos Farmacêuticos, Lda.; LABORATORIOS ATRAL S.A.
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- NeuraxPharm · Tax ID 515471224
- Awardee
- OCTAPHARMA, PRODUTOS FARMACÊUTICOS, LDA. · Tax ID 502820780
- Awardee
- MOONSURGE-MATERIAL MEDICO,LDA. · Tax ID 506657035
- Awardee
- Sanofi - Produtos Farmacêuticos, Lda · Tax ID 500134960
- Awardee
- SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
- Awardee
- FRESENIUS KABI PHARMA PORTUGAL, LDA. · Tax ID 504293753
- Awardee
- JANSSEN CILAG FARMACEUTICA, LDA. · Tax ID 500189412
- Awardee
- BAXTER MEDICO – FARMACEUTICA · Tax ID 503347345
- Awardee
- MYLAN, LDA · Tax ID 502248793
- Awardee
- LABORATÓRIO MEDINFAR - PRODUTOS FARMACÊUTICOS, SA · Tax ID 500384045
- Awardee
- ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
- Awardee
- LABESFAL, Laboratório Almiro S.A. · Tax ID 501169580
- Awardee
- Vifor Pharma Portugal, S.A. · Tax ID 516677586
- Awardee
- ITF Medivida, Produtos Farmacêuticos, Lda. · Tax ID 513026436
- Awardee
- LABORATORIOS ATRAL S.A. · Tax ID 500162085
Matches in the records
- MYLAN, LDA and Vifor Pharma Portugal, S.A. share an address · Source: TED (Jornal Oficial da UE), aviso 604352-2025 · Source: TED (Jornal Oficial da UE), aviso 349614-2026
Address and group matches come from the records cited and say only what those records show.
Values and timeline
- Contract price
- €37,947.76
- Procedure base price
- €37,947.76
- Total effective price
- Not reported on Portal BASE
- Publication date
- 8 May 2024
- Award date
- 18 April 2024
- Signing date
- 18 April 2024
- Performance period
- 12 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- 304/2023 - Medicamentos do grupo 4: sangue
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7033694
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.